Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease.

about

Longitudinal expression profiling of CD4+ and CD8+ cells in patients with active to quiescent giant cell arteritis

P2860

Q57727498-8B1F1AF7-D2A9-40CB-9181-18820E417402

P2860

Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease.

Item

http://www.wikidata.org/entity/Q38675714

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Effects of lifestyle intervent ...... alcoholic fatty liver disease.

@en

type

Item

label

Effects of lifestyle intervent ...... alcoholic fatty liver disease.

@en

prefLabel

Effects of lifestyle intervent ...... alcoholic fatty liver disease.

@en

P1476

Effects of lifestyle intervent ...... -alcoholic fatty liver disease

@en

P2093

Adrian Bauman

http://www.w3.org/2001/XMLSchema#string

Alexis St George

http://www.w3.org/2001/XMLSchema#string

Holger Jon Møller

http://www.w3.org/2001/XMLSchema#string

Jacob George

http://www.w3.org/2001/XMLSchema#string

Konstantin Kazankov

http://www.w3.org/2001/XMLSchema#string

Sidsel Rødgaard-Hansen

http://www.w3.org/2001/XMLSchema#string

P2860

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

The burden of liver disease in Europe: a review of available epidemiological data.

Soluble CD163.

Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.

Soluble CD163 from activated macrophages predicts mortality in acute liver failure.

Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease

Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.

Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.

The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children.

Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).

P304

498-504

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00365513.2017.1346823

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Henning Grønbæk

P577

2017-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28715286

http://www.w3.org/2001/XMLSchema#string

Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease.

about

P2860

P2860

Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698